Fortis Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fortis Advisors's PFE Position: Q2 2023 in Review
Fortis Advisors sold out of Pfizer (PFE) in Q2 2023, closing a stake of 225 shares — an estimated $9.18K sold.
Fortis Advisors first reported a position in PFE in Q3 2017 and held it in 23 quarters. The position peaked at $13K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Fortis Advisors reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
- Fortis Advisors sold 225 Pfizer shares in Q2 2023, an estimated $9.18K.
- Fortis Advisors first reported a position in Pfizer in Q3 2017 and held it in 23 quarters.
- Fortis Advisors's Pfizer position peaked at $13K in Q4 2021.
- 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Fortis Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.